Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instability.
Boyer C, Sefrioui D, Cohen R, Chautard R, Perrier M, Lebrun H, Goujon G, Hautefeuille V, Dior M, Walter T, Mary F, Manfredi S, Caroli-Bosc FX, Cervantes B, Coriat R, Deluche E, Zaanan A, Olivier R, Bouché O, Piessen G, Lecomte T, Louvet C, Michel P, Aparicio T, André T, Taieb J, Randrian V, Tougeron D. Boyer C, et al. Among authors: louvet c. Dig Liver Dis. 2023 Jan;55(1):123-130. doi: 10.1016/j.dld.2022.03.011. Epub 2022 Apr 6. Dig Liver Dis. 2023. PMID: 35397988
[Colon cancer: what is new in 2004?].
André T, Louvet C, de Gramont A. André T, et al. Among authors: louvet c. Bull Cancer. 2004 Jan;91(1):75-80. Bull Cancer. 2004. PMID: 14975808 Free article. Review. French.
First-line therapy for advanced colorectal cancer.
de Gramont A, Tournigand C, Louvet C, Maindrault-Goebel F, André T. de Gramont A, et al. Among authors: louvet c. Curr Oncol Rep. 2005 May;7(3):167-72. doi: 10.1007/s11912-005-0069-y. Curr Oncol Rep. 2005. PMID: 15847706 Review.
OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study.
Tournigand C, Cervantes A, Figer A, Lledo G, Flesch M, Buyse M, Mineur L, Carola E, Etienne PL, Rivera F, Chirivella I, Perez-Staub N, Louvet C, André T, Tabah-Fisch I, de Gramont A. Tournigand C, et al. Among authors: louvet c. J Clin Oncol. 2006 Jan 20;24(3):394-400. doi: 10.1200/JCO.2005.03.0106. J Clin Oncol. 2006. PMID: 16421419 Clinical Trial.
Phase II trial alternating FOLFOX-6 and FOLFIRI regimens in second-line therapy of patients with metastatic colorectal cancer (FIREFOX study).
Hebbar M, Tournigand C, Lledo G, Mabro M, André T, Louvet C, Aparicio T, Flesch M, Varette C, de Gramont A; Oncology Multidisciplinary Research Group (GERCOR). Hebbar M, et al. Among authors: louvet c. Cancer Invest. 2006 Mar;24(2):154-9. doi: 10.1080/07357900500524397. Cancer Invest. 2006. PMID: 16537184 Clinical Trial.
Targeted agents for adjuvant therapy of colon cancer.
de Gramont A, Tournigand C, André T, Larsen AK, Louvet C. de Gramont A, et al. Among authors: louvet c. Semin Oncol. 2006 Dec;33(6 Suppl 11):S42-5. doi: 10.1053/j.seminoncol.2006.10.006. Semin Oncol. 2006. PMID: 17178286 Review.
309 results